Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 306-317
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.306
Figure 2
Figure 2 Study design. Four intramuscular injections of either DNA vaccine (DNA Vacc.) or placebo mediated by in vivo electroporation were given to each patient. LAM: Lamivudine. SOT: Start of treatment (black arrow); EOT: End of treatment.

  • Citation: Yang FQ, Rao GR, Wang GQ, Li YQ, Xie Y, Zhang ZQ, Deng CL, Mao Q, Li J, Zhao W, Wang MR, Han T, Chen SJ, Pan C, Tan DM, Shang J, Zhang MX, Zhang YX, Yang JM, Chen GM. Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy. World J Gastroenterol 2017; 23(2): 306-317
  • URL: https://www.wjgnet.com/1007-9327/full/v23/i2/306.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v23.i2.306